Trial intelligence / Profile preview

E-cigarettes and Nicotine Pouches for Smoking Cessation in Pakistan

NCT05715164Phase 1Unknown

Sponsor
Alternative Research Initiative
Start
Dec 2023
Primary completion
Apr 2024
Countries
1
01

Overview

Phase 1, randomised, open-label trial (3 arms), sponsored by Alternative Research Initiative. Primary endpoints: Number of participants reported adverse events of e-cigarettes or nicotine pouches at 60 Weeks, Change in the number of combustible cigarettes per day at 60 Weeks and 1 more. Status: unknown.

Beyond the preview

Go deeper on NCT05715164.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05715164.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call